These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26152321)

  • 1. Perceptual distortions and delusional thinking following ketamine administration are related to increased pharmacological MRI signal changes in the parietal lobe.
    Stone J; Kotoula V; Dietrich C; De Simoni S; Krystal JH; Mehta MA
    J Psychopharmacol; 2015 Sep; 29(9):1025-8. PubMed ID: 26152321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis.
    Mason OJ; Morgan CJ; Stefanovic A; Curran HV
    Schizophr Res; 2008 Aug; 103(1-3):138-42. PubMed ID: 18387788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
    De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
    Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ketamine on brain function during smooth pursuit eye movements.
    Steffens M; Becker B; Neumann C; Kasparbauer AM; Meyhöfer I; Weber B; Mehta MA; Hurlemann R; Ettinger U
    Hum Brain Mapp; 2016 Nov; 37(11):4047-4060. PubMed ID: 27342447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that Subanesthetic Doses of Ketamine Cause Sustained Disruptions of NMDA and AMPA-Mediated Frontoparietal Connectivity in Humans.
    Muthukumaraswamy SD; Shaw AD; Jackson LE; Hall J; Moran R; Saxena N
    J Neurosci; 2015 Aug; 35(33):11694-706. PubMed ID: 26290246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.
    Deakin JF; Lees J; McKie S; Hallak JE; Williams SR; Dursun SM
    Arch Gen Psychiatry; 2008 Feb; 65(2):154-64. PubMed ID: 18250253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence.
    D'Souza DC; Singh N; Elander J; Carbuto M; Pittman B; Udo de Haes J; Sjogren M; Peeters P; Ranganathan M; Schipper J
    Neuropsychopharmacology; 2012 Mar; 37(4):1036-46. PubMed ID: 22113087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
    McMillan R; Sumner R; Forsyth A; Campbell D; Malpas G; Maxwell E; Deng C; Hay J; Ponton R; Sundram F; Muthukumaraswamy S
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109838. PubMed ID: 31843628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.
    Corlett PR; Honey GD; Aitken MR; Dickinson A; Shanks DR; Absalom AR; Lee M; Pomarol-Clotet E; Murray GK; McKenna PJ; Robbins TW; Bullmore ET; Fletcher PC
    Arch Gen Psychiatry; 2006 Jun; 63(6):611-21. PubMed ID: 16754834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
    Yurgelun-Todd DA; Renshaw PF; Goldsmith P; Uz T; Macek TA
    Psychopharmacology (Berl); 2020 Feb; 237(2):317-328. PubMed ID: 31773211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological modulation of the effects induced by ketamine at subanesthetic doses].
    Mechri A; Micallef J; Blin O; Saoud M; Daléry J; Gaha L
    Therapie; 2001; 56(5):617-22. PubMed ID: 11806303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychological effects of ketamine in healthy volunteers. Phenomenological study.
    Pomarol-Clotet E; Honey GD; Murray GK; Corlett PR; Absalom AR; Lee M; McKenna PJ; Bullmore ET; Fletcher PC
    Br J Psychiatry; 2006 Aug; 189():173-9. PubMed ID: 16880489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal dynamics of the pharmacological MRI response to subanaesthetic ketamine in healthy volunteers: A simultaneous EEG/fMRI study.
    McMillan R; Forsyth A; Campbell D; Malpas G; Maxwell E; Dukart J; Hipp JF; Muthukumaraswamy S
    J Psychopharmacol; 2019 Feb; 33(2):219-229. PubMed ID: 30663520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
    Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
    Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the BOLD MR signal to differentiate the stereoisomers of ketamine in the rat.
    Littlewood CL; Cash D; Dixon AL; Dix SL; White CT; O'Neill MJ; Tricklebank M; Williams SC
    Neuroimage; 2006 Oct; 32(4):1733-46. PubMed ID: 16815040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI).
    Yu H; Li Q; Wang D; Shi L; Lu G; Sun L; Wang L; Zhu W; Mak YT; Wong N; Wang Y; Pan F; Yew DT
    Neurotoxicology; 2012 Jan; 33(1):70-7. PubMed ID: 22178134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging the neuroplastic effects of ketamine with VBM and the necessity of placebo control.
    Höflich A; Ganger S; Tik M; Hahn A; Kranz GS; Vanicek T; Spies M; Kraus C; Windischberger C; Kasper S; Winkler D; Lanzenberger R
    Neuroimage; 2017 Feb; 147():198-203. PubMed ID: 27986606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMDA hypofunction in the posterior cingulate as a model for schizophrenia: an exploratory ketamine administration study in fMRI.
    Northoff G; Richter A; Bermpohl F; Grimm S; Martin E; Marcar VL; Wahl C; Hell D; Boeker H
    Schizophr Res; 2005 Jan; 72(2-3):235-48. PubMed ID: 15560968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine-Induced Hallucinations.
    Powers AR; Gancsos MG; Finn ES; Morgan PT; Corlett PR
    Psychopathology; 2015; 48(6):376-85. PubMed ID: 26361209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
    D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
    Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.